Increased smooth muscle cell activation and neointima formation in response to injury in AIF-1 transgenic mice

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 28, Issue 1, 2008, Pages 47-53

  Sommerville, Laura J ^a   Kelemen, Sheri E ^a   Autieri, Michael V ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allograft inflammatory factor 1; Carotid ligation; Proliferation; Signal transduction

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; KI 67 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE P38; P21 ACTIVATED KINASE 1; TRANSGELIN;

ABDOMINAL AORTA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY LIGATION; CELL ACTIVATION; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; INTIMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STATISTICAL SIGNIFICANCE; TRANSGENIC MOUSE; VASCULAR SMOOTH MUSCLE;

ANIMALS; CALCIUM-BINDING PROTEINS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; HYPERPLASIA; MICE; MICE, TRANSGENIC; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROMOTER REGIONS (GENETICS); SIGNAL TRANSDUCTION; TUNICA INTIMA;

EID: 37549043130     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.107.156794     Document Type: Article

References (31)

1. Welt FGP, Rogers C. Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol. 2002;22:1769-1776.
2. Ventura HO, Mehra MR, Smart FW. Cardiac allograft vasculopathy: current concepts. Am Heart J. 1995;129:791-798.
3. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
4. IP J, Fuster V, Badimon L, Badimon J, Taubman M, Chesebro J. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiology. 1990;15:1667-1687.
5. Hung AY, Sheng M. PDZ domains: structural modules for protein complex assembly. J Biol Chem 2002;277: 5699-5702.
6. Chen J, DeVivo M, Dingus J, Harry A, Li J, Sui J, Carty DJ, Blank JL, Exton JH, Stoffel RH, et al. A region of adenylyl cyclase 2 critical for regulation by G protein beta gamma subunits. Science. 1995;268: 1166-1169.
7. Deininger MH, Meyermann R, Schluesener HJ. The allograft inflammatory factor-1 family of proteins. FEBS Lett. 2002;514:115-121.
8. Utans U, Arceci R, Yamashita Y, Russell M. Cloning and characterization of allograft Inflammatory Factor-1: A novel macrophage factor identified in rat cardiac allografts with chronic rejection. J Clin Investigation. 1995;95:2954-2962.
9. Schluesener HJ, Seid K, Meyermann R. Effects of autoantigen and dexamethasone treatment on expression of endothelial-monocyte activating polypeptide II and Allograft-Inflammatory Factor-1 by activated macrophages and microglial cells in lesions of experimental autoimmune encephalomyelitis, neuritis, and uveitis. Acta Neuropathol. 1999;97: 119-126.
10. Kruse M. Steffen R, Batel R, Muler I, Muller W. Differential expression of allograft inflammatory factor 1 and of glutathione peroxidase during auto-and allograft response in marine sponges. J Cell Science. 1999;112: 4305-4313.
11. Iris FMJ, Bougueleret L, Prieur S, Caterina D, Primas G, Perrot V, Jurka J, Rodriguez-Tome P, Claverie JM, Dausset J, Cohen D Dense Alu clustering and a potential new member of the NF-kB family within a 90 kilobase HLA class III segment. Nat Genet 1993;3:137-145.
12. Autieri MV, Mu A, and Carbone C. Expression of Allograft Inflammatory Factor-1 (AIF1) is a marker of activated human VSMC and arterial injury. Arterioscler Thromb Vasc Biol. 2000;20:1737-1744.
13. Autieri MV, Kelemen SE, Thomas BA, Feller ED, Goldman BI, Eisen HJ. Allograft Inflammatory Factor-1 (AIF-1) expression correlates with cardiac rejection and development of cardiac allograft vasculopathy. Circulation. 2002;106:2218-2223.
14. Autieri MV, Kelemen SE, Wendt KW. AIF-1 is an actin-polymerizing and Rac1-activating protein that promotes vascular smooth muscle cell migration. Circ Res. 2003;92:1107-1114.
15. Autieri MV, Carbone CM. Over expression of Allograft Inflammatory Factor-1 promotes proliferation of vascular smooth muscle cells by cell cycle deregulation. Arterioscler Thromb Vasc Biol. 2001;21:1421-1426.
16. Tian Y, Kelemen SE, Autieri MV. Inhibition of AIF-1 expression by constitutive siRNA expression reduces macrophage migration, proliferation, and signal transduction initiated by atherogenic stimuli. Am J Physiol Cell Physiol. 2006;290:C1083-C1089.
17. Regan CP, Adam PJ, Madsen CS, Owens GK. Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury. J Clin Invest. 2000;106:1139-1147.
18. Wamhoff BR, Hoofnagle MH, Burns A, Sinha S, McDonald OG, Owens GK. A G/C element mediates repression of the SM22alpha promoter within phenotypically modulated smooth muscle cells in experimental atherosclerosis. Circ Res. 2004;95:981-988.
19. Kumar A, Lindner V. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol. 1997;17:2238-2244.
20. Harmon KJ, Couper LL, Lindner V. Strain-dependent vascular remodeling phenotypes in inbred mice. Am J Pathol. 2000;156: 1741-1748.
21. Ray JL, Leach R, Herbert JM, Benson M. Isolation of vascular smooth muscle cells from a single murine aorta. Methods Cell Sci. 2001;23: 85-88.
22. Tenhunen O, Rysa J, Ilves M, Soini Y, Ruskoaho H, Leskinen H. Identification of cell cycle regulatory and inflammatory genes as predominant targets of p38 mitogen-activated protein kinase in the heart. Circ Res 2006;99:485-493.
23. Edwards DC, Sanders LC, Bokoch GM, Gill GN. Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics. Nat Cell Biol. 1999 1:253-259.
24. ERK JNK and p38 MAP kinases differentially regulate proliferation and migration of phenotypically distinct smooth muscle cell subtypes. Kavurma MM, Khachigian LM. J Cell Biochem. 2003;89:289-300.
25. Ohashi N, Matsumori A, Furukawa Y, Ono K, Okada M, Iwasaki A, Miyamoto T, Nakano A, Sasayama S. Role of p38 mitogen-activated protein kinase in neointimal hyperplasia after vascular injury. Arterioscler Thromb Vasc Biol. 2000;20:2521-2526.
26. Autieri MV, Chen X. The ability of AIF-1 to activate human vascular smooth muscle cells is lost by mutations in the EF-hand calcium-binding region. Exp Cell Res. 2005;307:204-211.
27. Dechert MA, Holder JM, Gerthoffer WT. p21-activated kinase 1 participates in tracheal smooth muscle cell migration by signaling to p38 MAPK Am J Physiol Cell Physiol. 2001;281:C123-C132.
28. Chen X, Kelemen SE, Autieri MV. AIF-1 Expression Modulates Proliferation of human vascular smooth muscle cells by autocrine expression of G-CSF. Arterioscler Thromb Vasc Biol. 2004;24:1217-1222.
29. Zhao ZS, Manser E. PAK and other Rho-associated kinases-effectors with surprisingly diverse mechanisms of regulation. Biochem J. 2005; 386:201-214.
30. Knaus UG, Wang Y, Reilly AM, Warnock D, Jackson JH. Structural requirements for PAK activation by Rac GTPases. J Biol Chem. 1998; 273:21512-21518.
31. Weber DS, Taniyama Y, Rocic P, Seshiah PN, Dechert MA, Gerthoffer WT, Griendling KK. Phosphoinositide-dependent kinase 1 and p21-activated protein kinase mediate reactive oxygen species-dependent regulation of platelet-derived growth factor-induced smooth muscle cell migration. Circ Res. 2004;94:1219-1226.